Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.

Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc. 2002 Jun; 50(6):1165-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.